EGLN1 and neoplasm: Interestingly, the effect on CAF activity relies on PHD2 deletion on tumor cells, but not on CAFs as PHD2 deficiency in platelet-derived growth factor receptor α (PDGFRα)-positive CAFs does not influence metastasis [31].